Search for: "WATSON PHARMACEUTICALS "
Results 261 - 280
of 359
Sort by Relevance
|
Sort by Date
14 Jul 2010, 7:53 am
Watson Pharmaceuticals, Inc., 211 F.3d 21 (2d Cir. 2000). [read post]
27 Jun 2010, 10:37 pm
It targets the companies Pliva Pharmaceuticals, Barr Laboratories, Teva Pharmaceuticals and Watson Pharmaceuticals — all are generic manufacturers of Reglan. [read post]
3 Jun 2010, 2:23 pm
In 2003, pursuant to the Hatch-Waxman Act, two generic companies, Watson Pharmaceuticals and Paddock Laboratories (in partnership with Par Pharmaceuticals), each filed Abbreviated New Drug Applications ("ANDAs") with the FDA, seeking to market much cheaper, generic versions of AndroGel well before the expiration of Solvay's patent in 2020. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
31 May 2010, 11:57 am
Astellas Pharma acquisition of OSI Pharmaceuticals ($4 billion) – It only cost Japanese Astellas $500 million to switch this deal from hostile to negotiated. [read post]
24 May 2010, 7:46 am
Watson (08-6261): writ of cert. dismissed as improvidently granted in a per curiam opinion. [read post]
20 May 2010, 9:55 pm
Court of Appeals for the Second Circuit ruled that the "pay-for-delay" agreement between defendants Bayer AG and several generic drugmakers (including The Rugby Group, Watson Pharmaceuticals Inc., and Barr Laboratories Inc.) were not illegal under U.S. antitrust law and prevailing precedent. [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
9 May 2010, 9:58 pm
Watson Pharmaceuticals, Inc. et al. 2:10-cv-00647; filed May 5, 2010 in the District Court of Nevada • Plaintiff: Eli Lilly & Company • Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
6 May 2010, 4:12 pm
Novartis Pharmaceuticals Corp., 564 F. [read post]
5 May 2010, 4:46 am
Watson Pharmaceuticals, Inc. et al. [read post]
2 May 2010, 9:52 pm
• Defendants: Watson Pharmaceuticals Inc.; Watson... [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
26 Mar 2010, 12:33 pm
That the Board cites the commission of Towers Watson to do such work, an unproductive and irrelevant use of the shareholders’ money, confirms my assertion. [read post]
24 Mar 2010, 11:33 am
Ariad Pharmaceuticals et al v. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
4 Mar 2010, 12:09 pm
Please RSVP with Faye Watson (cotton@msu.edu or call 517-353-3174).To learn more about the seminar topic, see Mr. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
25 Feb 2010, 6:18 am
Watson Pharmaceuticals, Inc., Watson was selling a gout medication, which, it argued, was grandfathered. [read post]
